|
|
|
|
|
|
|
|
|
|
|
|
|
Overcoming Product Instability And Improving Yield
|
|
Case Study | Grace Fine Chemical Manufacturing Services
|
Early identification of hidden product instability enabled rapid process adjustments, improving yield and keeping a preclinical toxicology program on track despite challenging reaction conditions.
|
|
|
|
|
|
Integrating Molecular Design And Enabling Formulation
|
|
Poster | Bend Bioscience
|
Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.
|
|
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma
|
"I should have known," writes Chief Editor Louis Garguilo, "It takes an accomplished biologist to most effectively describe the significance of artificial intelligence in our outsourcing industry and how to put it to practical use." That professional is Damiano Dragone, Founder & Principal Advisor, Dragone Consulting, who built a career across pharmaceutical quality and data-driven quality environments within the biopharmaceutical industry, and was an early proponent of the promise of AI in development and manufacturing processes and facilities.
|
|
|
|
|
|
|
|
INDUSTRY INSIGHTS CONTINUED
|
|
|
|
|
|
|
|
Sterile Filtration Following Aseptic Processing
|
|
Article | Curia
|
When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.
|
|
|
|
|
|
Accelerating Development And Enhancing Pipeline Value
|
|
White Paper | Thermo Fisher Scientific
|
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a streamlined partner.
|
|
|
|
|
|
Balancing Speed And Compliance In Oral Dosage Development
|
|
White Paper | By Saujanya Gosangari, Alcami
|
This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.
|
|
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE
|
|
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
|
